---  
layout: startup_page  
title: "Debiopharm"  
id: "debiopharm.com"  
permalink: "/debiopharmdebiopharm.com11212024/"  
website: "https://www.debiopharm.com/"  
funding_round: "Preclinical Development"  
funding_amount: "$5.76M"  
investors: "CARB-X"  
about: "Debiopharm is a global biopharmaceutical company focused on developing innovative therapies to address high unmet medical needs, primarily in oncology and bacterial infections. They develop high-potential compounds and technologies, clinically demonstrate their safety and efficacy, and then partner with larger pharmaceutical companies for global commercialization. Currently, they are developing Debio 1453, a novel antibiotic to combat drug-resistant Neisseria gonorrhoeae infections."  
markets: "Pharmaceuticals, Antibacterial, Infectious Diseases"  
hq: "Lausanne, Vaud, Switzerland"  
founded_year: "1979"  
linkedin: "https://www.linkedin.com/company/debiopharminternational/"  
twitter: "http://twitter.com/DebiopharmNews"  
instagram: ""  
facebook: "http://www.facebook.com/pages/Debiopharm-Group"  
crunchbase: "https://www.crunchbase.com/organization/debiopharm"  
pitchbook: ""  

date_display: "21-Nov-2024"  
date: "2024-11-21"

# SEO Optimization  
meta_title: "Debiopharm - Preclinical Development Funding ($5.76M)"  
meta_description: "Debiopharm, Debiopharm is a global biopharmaceutical company focused on developing innovative therapies to address high unmet medical needs, primarily in oncology..."  
meta_keywords: "Debiopharm, Pharmaceuticals, Antibacterial, Infectious Diseases, Preclinical Development funding"  
canonical_url: "https://startup.projectstartups.com/debiopharmdebiopharm.com11212024/"  
---